Migraine Research Frontiers: Genetics, CGRP, Neuromodulation, and Personalized Medicine

Migraine research has advanced across multiple domains:

  1. Genetics/GWAS: >100 loci identified; shared with vascular, neuronal pathways.
  2. Neuroimaging: fMRI, PET reveal hypothalamic, brainstem, cortical activation during attacks; structural changes in chronic migraine.
  3. Trigeminovascular system: Central role of CGRP, PACAP, glutamate.
  4. CGRP‑targeted therapies: Monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) and gepants (ubrogepant, rimegepant, atogepant) – transformative for acute and preventive treatment.
  5. Serotonin (5‑HT₁F) agonists: Lasmiditan (acute, no vasoconstriction).
  6. Neuromodulation: Non‑invasive (eTNS, nVNS, sTMS) and invasive (SPG stimulation).
  7. Comorbidities & triggers: Sleep, stress, hormones, diet, obesity – bidirectional links.
  8. Sex differences: Estrogen modulation explains female predominance.
  9. Biomarkers: CGRP, calcitonin, neurofilament light, imaging signatures for prediction/response.
  10. Long‑term outcomes: Medication‑overuse headache, chronic migraine progression, cardiovascular risk.

Precision medicine—matching therapy to phenotype/genotype—is the emerging paradigm.

Migraine - Related Articles